ScreenerHero
BOIBoiron SA
EPA · FR · Healthcare · Drug Manufacturers - Specialty & Generic · boiron.fr
26.20EUR0.00%Mkt Cap: 492.56M $P/E: 13.88

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers homeopathic medicines and homeopathic specialties; and other healthcare products, i…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$65.19BUSDP/E 23.7
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.41BUSDP/E 20.1
ZOE
Zoetis Inc.
$29.89BUSDP/E 12.7
UTHR
United Therapeutics Corporation
$22.70BUSDP/E 19.0
VTRS
Viatris, Inc.
$18.66BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.39BUSDP/E 118.0
NBIX
Neurocrine Biosciences, Inc.
$15.81BUSDP/E 22.8
IPN
Ipsen S.A.
$14.67BUSDP/E 26.4
ELAN
Elanco Animal Health Incorporat
$12.24BUSD
KRK
Krka, d. d.
$8.57BUSDP/E 18.8
HIMS
Hims & Hers Health, Inc.
$7.25BUSD
LQDA
Liquidia Corporation
$6.74BUSDP/E 53.8
LNTH
Lantheus Holdings Inc
$6.56BUSDP/E 24.0
AMRX
Amneal Pharmaceuticals, Inc.
$6.23BUSDP/E 37.3
INDV
Indivior PLC Ordinary Shares
$4.61BUSDP/E 14.0
HIK
Hikma Pharmaceuticals PLC
$4.32BUSDP/E 12.5
AMLX
Amylyx Pharmaceuticals Inc. Common Stock
$4.30BUSD
SFZN
Siegfried Holding AG
$3.91BUSDP/E 20.4
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.32BUSDP/E 16.5
SUPN
Supernus Pharmaceuticals, Inc.
$2.82BUSD

Key Statistics

Company
Market Cap492.56M $
Enterprise Value438.68M $
Revenue (TTM)544.68M $
Gross Profit397.53M $
Net Income (TTM)35.48M $
Revenue/Share31.37 USD
Last Price26.20 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.4K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)13.88
P/E (Forward)12.21
PEG2.38
EV/EBITDA5.84
EV/Revenue0.81
P/S0.90
P/B1.15
EPS (TTM)1.88
EPS (Forward)2.13
52W Range
21.0046% of range32.25
52W High32.25 EUR
52W Low21.00 EUR
Profitability
Gross Margin72.98%
Oper. Margin11.60%
EBITDA Margin13.80%
Profit Margin6.51%
ROE8.31%
ROA5.42%
Growth
Revenue Growth-1.40%
Earnings Growth165.90%
Cash Flow & Leverage
Operating CF57.87M $
CapEx (TTM)25.57M $
FCF Margin10.59%
FCF Yield11.71%
Net Debt-52.02M $
Net Debt/EBITDA-0.69
Balance Sheet
Debt/Equity0.08
Current Ratio2.22
Quick Ratio1.43
Book Value/Sh22.62 EUR
Cash/Share4.569 EUR
Dividends
Fwd Div Rate1.350 EUR
Trail. Div Rate1.350 EUR
Div. Yield5.15%
5Y Avg Yield3.43%
Payout Ratio63.83%
Ex-Div DateJun 3, 2026
Pay Date—
Splits
Last Split4:1
Split DateJul 1, 2003
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.17.36M
Float3.50M
Insiders79.00%
Institutions5.37%
Technical
SMA 5027.30 (-4.0%)
SMA 20027.93 (-6.2%)
Beta0.22
S&P 52W Chg18.16%
Avg Vol (30d)2.13K
Avg Vol (10d)3.52K
Technical Indicators
RSI (14)40.0
MACD-0.2929
MACD Signal-0.2207
MACD Hist.-0.0722
BB Upper27.97 EUR
BB Middle26.86 EUR
BB Lower25.75 EUR
BB Width8.28%
ATR (14)0.4836 EUR
Vol Ratio (20d)0.43x